Immune to Cancer: The CRI Blog
-
From Progress to Possibility: A New Chapter in Cancer Research
At the 2026 American Association of Cancer Research (AACR) Annual Meeting, a clear message emerged from National… -
Cancer Clinical Trials: What Patients Should Know
If you or a loved one has been diagnosed with cancer, you’ve likely heard the term “clinical… -
Noodling the Impact of AI on the Immunotherapy Landscape at Cancer Progress 2026
At Lumanity’s Cancer Progress 2026, the goal wasn’t just to showcase innovation — it was to pressure-test… -
Decoding the Tumor: Inside the AI-Driven Hunt for Colorectal Cancer Immunotherapy
Colorectal cancer (including colon cancer and rectal cancer) is the second leading cause of cancer-related death in… -
Disrupting the Status Quo: How Women are Carrying the Future of Immunotherapy Forward
Women have long played a transformative role in science — often challenging convention, expanding knowledge, and opening… -
A Lifesaving Legacy and Enduring Commitment to Research: The Landesman Family
Each year, a community gathers with a shared purpose: to honor a life lost too soon and… -
Kidney Cancer and Immunotherapy: What Patients Should Know
A kidney cancer diagnosis can bring uncertainty, fear, and a lot of questions. If you or someone… -
Key Insights from IO360°: A Transformative Decade in Cancer Immunotherapy
At February’s IO360° Summit in Boston, hundreds of researchers, clinicians, patient advocates, and biotech leaders gathered to… -
Colorectal Cancer Rates Are Skyrocketing in Young Adults — Is Your Lifestyle Putting You at Risk?
If you’re under 50, colorectal cancer probably isn’t on your radar. It should be. Once considered a…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.